Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Moderna's Shares Could Take Off if These 2 Things Happen
06:00am, Saturday, 30'th Sep 2023
Moderna has announced progress on late-stage programs and forecasts billion-dollar earnings down the road, but the stock continues to stagnate. Investors might be waiting for concrete signs of success
Here's Why You Should Consider Moderna Stock, and No, It's Not the COVID Vaccine
05:30am, Saturday, 30'th Sep 2023
Revenue from Moderna's COVID vaccine will continue for the foreseeable future. Moderna has a deep pipeline with several products in phase 3 trials.
Is it Time to Buy Pfizer, Moderna, or AstraZeneca's Stock?
11:18pm, Thursday, 28'th Sep 2023
Despite slowing COVID-19 vaccine sales these healthcare titans are trading at more reasonable valuations with a lot of the risk-to-reward being priced into their stocks considering their earnings pote
Don't Miss the Boom: 3 Healthcare Stocks Set to Explode Higher
02:26pm, Tuesday, 26'th Sep 2023
According to the American Medical Association, U.S. healthcare spending totaled $4.3 trillion in 2021, equal to nearly $13,000 per person. Overall medical expenses account for nearly 20% of U.S. gross
Wall Street analysts expect the S&P 500 to rise 19% over the next 12 months. Here are their 10 favorite stocks.
08:38am, Tuesday, 26'th Sep 2023
Outside of a handful of highflying technology stocks, U.S. stocks have been practically flat in 2023, but on Wall Street, some analysts remain as bullish as ever.
EU in talks with Moderna over new COVID vaccine deal - FT
08:21am, Tuesday, 26'th Sep 2023
The European Union is in talks with Moderna over a new procurement deal for the company's COVID-19 vaccines amid concerns over a rise in infections in the region, the Financial Times reported on Tuesd
Beware! 3 Healthcare Stocks Waving Massive Red Flags Right Now.
04:00pm, Sunday, 24'th Sep 2023
Healthcare stocks generally offer a lot of upside. The cost of healthcare is incredibly expensive in the United States and the companies that deliver it tend to do very well overall.
The Score: Moderna, Splunk, Fox and More Stocks That Defined the Week
06:48pm, Friday, 22'nd Sep 2023
Here are some of the major companies whose stocks moved on the week's news.
Moderna Is Expecting Massive Growth Over the Next Decade. Is the Stock a No-Brainer Buy?
08:45am, Friday, 22'nd Sep 2023
Moderna is investing in such areas as oncology, rare diseases, and infectious diseases. The biotech projects it could bring in $30 billion in annual sales 10 years from now.
Moderna: Covid Curse
08:00pm, Thursday, 21'st Sep 2023
Moderna, Inc. revenues have now slumped due to lower Covid vaccine demand, but the company ramped up aggressive spending on R&D. The company faces up to $8 per share of losses in 2024 to 2025 due to t
Does This Message From Moderna Mean Bad News for Novavax?
07:30am, Thursday, 21'st Sep 2023
Moderna and Novavax both are focused on the coronavirus vaccine market of the future. The two companies each are developing vaccine candidates to prevent coronavirus and flu.
Beware! 3 Biotech Stocks Waving Massive Red Flags Right Now
11:28am, Wednesday, 20'th Sep 2023
The biotech sector never fails to offer up stocks full of massive issues at any given time. Developing novel therapeutic devices and pharmaceuticals is, after all, very expensive.
Fall Covid shot rollout gets off to a bumpy start as some patients see insurance delays
10:56am, Wednesday, 20'th Sep 2023
The reports are fueling confusion among insured patients about whether they can still access Covid shots for free — just as cases tick up across the country.
With New COVID-19 Boosters in Tow, Which Is the Better Buy: Pfizer, BioNtech, or Moderna Stock?
07:45am, Wednesday, 20'th Sep 2023
Facing significant patent cliffs, Pfizer is putting faith in new launches. Moderna has nearly doubled its pipeline in three years.
Beware! 3 Value Stocks Waving Massive Red Flags Right Now.
07:30am, Wednesday, 20'th Sep 2023
Value stocks are the perfect haven in today's choppy stock market. Instead of looking to high-flying tech stocks, many investors are flocking to companies with low price-to-book ratios and other under
